Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

A, Nice N Clinical Trials

A listing of A, Nice N clinical trials actively recruiting patients volunteers.

RESULTS

Found (19) clinical trials

This is a placebo controlled trial to test the efficacy and safety of AMG 301 in the prevention of episodic and chronic migraine. The treatment period is 12 weeks and the total study duration is 35 weeks.

Phase

The purpose of this research study is to measure the effects of a study drug on body weight in young adults that have schizophrenia, schizophreniform or bipolar 1 disorder. This study will last approximately 20 weeks. There will be 11 study visits. Each visit lasts between 1 and 4 hours. ...

Phase N/A

This is a placebo controlled trial to test the efficacy and safety of CHF 5259 (glycopyrronium bromide). This is an 8 week treatment trial.

Phase

This is a 52 week trial comparing adalimumab versus secukinumab for the treatment of active psoriatic arthritis. Both treatments are FDA approved for psoriatic arthritis; however this study seeks to determine which drug is superior.

Phase

This is a 28 week study requiring a total of 3 clinic visits. Subjects will be treated with either a placebo or the study drug which is given intranasally. 

Phase

A global registry to study the demographics, socioeconomic and clinical factors, etiologies, pathophysiology, management, barriers to care, and outcomes of heart failure patients.

Phase N/A

The primary purpose of this study is to determine if the investigational medication, BHV-4157, is effective versus placebo in subjects with Obsessive Compulsive Disorder (OCD) who are not receiving adequate response to their current medication treatment.  After an initial screening period of 2 to 42 days, qualified participants will visit ...

Phase

The goal of this study is to compare changes in the female genital tract in women diagnosed with bacterial vaginosis (BV) before and after treatment and to compare differences in the female genital tract in adolescent and adult women. Women with BV have an increased risk of acquiring HIV and ...

Phase

The purpose of this study is to evaluate whether the investigational medication, JNJ-54861911, slows cognitive decline compared with placebo (inactive treatment) in individuals with generally normal memory and thinking ability but who are at risk for developing Alzheimer's dementia.  Study qualification and whether or not a potential study participant is ...

Phase

We are looking for people who have taken part in interview or focus group studies. We would like to get your views about what happens to the information collected about you. Participation will take less than 1 hour. There will be an online survey and an interview over the phone. ...

Phase N/A